Search Results - "He, Jiujiang" :: K.UTB vyhledávací portál

Long-term retrospective study of retinoic acid combined with arsenic and chemotherapy for acute promyelocytic leukemia

by Zhang, Xian, Wu, Shulan, Yang, Junfang, Zhang, Gailing, Su, Yunchao, Zhang, Min, He, Jiujiang, Shi, Yanze, Li, Wenqian, Lu, Peihua, Lu, Daopei
Published in International journal of hematology (01.04.2023)

Get full text

Journal Article

Loading…

$Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma$

Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma

by Huang, Lefu, Li, Jingjing, Yang, Junfang, Zhang, Xian, Zhang, Min, He, Jiujiang, Zhang, Gailing, Li, Wenqian, Wang, Hui, Li, Jianqiang, Lu, Peihua
Published in Cells (Basel, Switzerland) (01.12.2022)

Get full text

Journal Article

Loading…

A LncRNA-miRNA-mRNA ceRNA regulatory network based tuberculosis prediction model

by Feng, Jinfang, Bian, Qin, He, Xianwei, Zhang, Han, He, Jiujiang
Published in Microbial pathogenesis (01.09.2021)

Get full text

Journal Article

Loading…

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

by Zhang, Xian, Lu, Xin-an, Yang, Junfang, Zhang, Gailing, Li, Jingjing, Song, Lisong, Su, Yunchao, Shi, Yanze, Zhang, Min, He, Jiujiang, Song, Dan, Lv, Fanyong, Li, Wenqian, Wu, Yan, Wang, Hui, Liu, Hongxing, Zhou, Xiaosu, He, Ting, Lu, Peihua
Published in Blood advances (26.05.2020)

Get full text

Journal Article

Loading…

$Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients$

Feasibility, and Efficacy of Donor-Derived cd19-Targeted Car t-Cell Therapy in Refractory/Relapsed(r/r)b-Cell Acute Lymphoblastic Leukemia (b-all) Patients

by Zhang, Xian, Yang, Junfang, Li, Wenqian, Zhang, Gailing, Su, Yunchao, Shi, Yanze, Song, Dan, Zhang, Min, He, Jiujiang, Xu, Li, Qiu, Liyuan, Lu, Xin-An, Wu, Fei, Li, Jianqiang, Chen, Dandan, Li, Xiangqun, Li, Ziyu, Li, Jingjing, Lu, Peihua
Published in Blood (05.11.2020)

Get full text

Journal Article

Loading…

$Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia$

Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

by Zhang, Xian, Yang, Junfang, Li, Wenqian, Zhang, Gailing, Su, Yunchao, Shi, Yanze, Song, Dan, Zhang, Min, He, Jiujiang, Xu, Li, Li, Jingjing, Lu, Xinan, Li, Jianqiang, Li, Xiangqun, Xu, Zhongwei, Li, Ziyu, Lu, Peihua
Published in Blood (05.11.2020)

Get full text

Journal Article

Loading…

$A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)$

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

by Zhang, Xian, Wang, Jiasheng, Liu, Yue, Yang, Junfang, Li, Jingjing, Zhang, Gailing, Shi, Yanze, He, Jiujiang, Song, Dan, Li, Wenqian, Xia, Shulian, Zhang, Min, Zhou, Zhixiao, Jia, Lemei, Zheng, Hongli, Lin, Xin, Lu, Peihua
Published in Blood (05.11.2020)

Get full text

Journal Article

Loading…

$A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia$

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

by Yang, Junfang, He, Jiaping, Zhang, Xian, Wang, Zhenguang, Zhang, Yongliang, Cai, Songbai, Sun, Zhe, Ye, Xun, He, Yan, Shen, Lianjun, He, Jiujiang, Zhang, Gailing, Song, Dan, Zhang, Min, Hu, Xiaona, Li, Jingjing, Xia, Shulian, Xu, Li, Cao, Wei, Lu, Peihua
Published in Blood (13.11.2019)

Get full text

Journal Article

Loading…

$Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia$

Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia

by Yang, Junfang, Jiang, Pengfei, Zhang, Xian, Zhu, Xiaobin, Dong, Qi, He, Jiaping, Lin, Nanjing, Wang, Zhenguang, Cai, Songbai, Ye, Xun, Su, Yunchao, Li, Wenqian, Li, Jingjing, Yu, Ziyao, He, Jiujiang, Xu, Li, Song, Dan, Cao, Wei, Lu, Peihua
Published in Blood (13.11.2019)

Get full text

Journal Article

Loading…

5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia – a summary

by Zhang, Xian, Yang, Junfang, Zhang, Gailing, Song, Lisong, Su, Yunchao, Shi, Yanze, Zhang, Min, He, Jiujiang, Song, Dan, Lv, Fanyong, Wu, Ping, Wang, Hui, Wang, Tong, Zhang, Yang, Liu, Hongxing, Lu, Peihua
Published in Immunotherapy (01.01.2020)

Get full text

Journal Article